A Study to Assess Whether PDE5 Inhibitors Increase the Chance of Triggering the Onset of Acute NAION - NCT00759174-08901 (Clinical Trial 243213)
Permalink: http://www.ClinicalConnection.com/exp/ExpandedPatientViewStudy243213.aspx
|
** Please review additional "Nearby Studies" on right ----->
|
|
 |
 |
|
| City: |
|
New Brunswick |
|
State:
|
|
NJ |
| Zip Code: |
|
08901 |
| Conditions: |
|
Optic Neuropathy, Ischemic |
| Purpose: |
|
The objective of this non-interventional study is to examine whether use of
Phosphodiesterase Inhibitors (PDE5s), including use of sildenafil, vardenafil, or tadalafil,
triggers the onset of acute NAION.
|
| Study summary: |
|
|
| Criteria: |
|
Inclusion Criteria:
- Male aged ≥45 years;
- Experienced abrupt visual change in only 1 eye
Exclusion Criteria:
- Pain determined by an ophthalmologist to be consistent with an inflammatory/arteritic
process or optic neuritis;
- History of NAION or optic neuritis.
- Participation in other studies within 60 days prior to entry in the study. |
|
|
|
| Study is available at: |
|
Pfizer Investigational Site
New Brunswick, NJ 08901
United States
Primary Contact:
Pfizer CT.gov Call Center
Phone: 1-800-718-1021 |
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
February 16, 2010 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Clinical trials are medical research studies designed to test the safety and/or
effectiveness of new drugs, devices, or treatments in humans. These studies are
conducted worldwide for a range of conditions and illnesses. Learn more about
clinical research and participating in a study at
About Clinical Trials.
|
|
|
|
|